Drugs / reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA)
reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00760760 | Sep 2008 → Sep 2014 | morbid obesity, panniculitis | Medical University of Vienna | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | reesterified long-chain n-3 polyunsaturated fatty acids (EPA, DHA) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00760760 ↗ |